Unknown

Dataset Information

0

Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.

ABSTRACT: We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than expected for children with DS-ALL (54%) than for non-DS ALL. These data suggest leukemic relapse rather than transplant toxicity is the most important cause of treatment failure. Advancements in leukemia control are especially needed for improvement in HCT outcomes for DS-ALL.

SUBMITTER: Hitzler JK 

PROVIDER: S-EPMC4080799 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than expected for children with DS-ALL (54%) than for non-DS ALL. These data suggest leu  ...[more]

Similar Datasets

Unknown Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.
| S-EPMC3707801 | biostudies-literature
Unknown Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.
| S-EPMC3279631 | biostudies-literature
Unknown Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome.
| S-EPMC9327551 | biostudies-literature
Unknown Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
| S-EPMC6788009 | biostudies-literature
Unknown Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
| S-EPMC3879907 | biostudies-other
Transcriptomics Genomic profiling in Down syndrome pediatric acute lymphoblastic leukemia
2011-07-12 | GSE21094 | GEO
Unknown Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.
| S-EPMC2783810 | biostudies-literature
Transcriptomics Expression data from Down syndrome and non-Down syndrome pediatric acute lymphoblastic leukemia cases
2011-07-12 | GSE20910 | GEO
Transcriptomics Expression data from Down syndrome and non-Down syndrome pediatric acute lymphoblastic leukemia cases
2011-07-12 | E-GEOD-20910 | biostudies-arrayexpress
Unknown Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
| S-EPMC6778645 | biostudies-literature